{"gene":"DLX6","run_date":"2026-04-28T17:46:02","timeline":{"discoveries":[{"year":2002,"finding":"Combined targeted inactivation of Dlx5 and Dlx6 in mice results in severe craniofacial, axial, and appendicular skeletal abnormalities phenocopying split-hand/split-foot malformation (SHFM), and transgenic overexpression of Dlx5 in the apical ectodermal ridge of Dlx5/6 null mice fully rescues limb outgrowth, establishing Dlx5/Dlx6 as critical regulators of mammalian limb development.","method":"Targeted gene knockout (loss-of-function) and transgenic rescue in mice","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1–2 — clean KO with specific skeletal phenotype plus transgenic rescue, strong evidence","pmids":["12000792"],"is_preprint":false},{"year":2002,"finding":"Simultaneous inactivation of Dlx5 and Dlx6 in mice transforms the lower jaw into an upper jaw structure, constituting a homeotic-like transformation in the Hox-free mandibular arch, establishing Dlx5/Dlx6 as homeotic regulators of jaw identity.","method":"Double knockout mouse; morphological and histological analysis","journal":"Genesis (New York, N.Y. : 2000)","confidence":"High","confidence_rationale":"Tier 2 — clean double KO with defined jaw homeotic phenotype","pmids":["12434331"],"is_preprint":false},{"year":2000,"finding":"Dlx1 and Dlx2 proteins bind conserved homeodomain binding sites in the Dlx5/Dlx6 intergenic enhancer region to cross-regulate Dlx5 and Dlx6 expression in the developing forebrain; reporter transgene activity is drastically reduced in Dlx1/Dlx2 double mutants, and Dlx protein binding to the enhancer was confirmed by cotransfection and DNA-protein binding experiments.","method":"Transgenic reporter assay, cotransfection, DNA-protein binding (EMSA/binding assay), double-mutant epistasis","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods (reporter, binding assay, genetic epistasis), replicated across mouse and zebrafish","pmids":["10632600"],"is_preprint":false},{"year":2001,"finding":"Dlx6 protein binds to four homeodomain binding sites in the dHAND branchial arch enhancer in an endothelin-1 (ET-1)/endothelin receptor A (EdnrA)-dependent manner, linking ET-1 signaling to dHAND transcription during craniofacial morphogenesis; Dlx6 expression is down-regulated in EdnrA mutant branchial arches.","method":"Protein binding comparison between EdnrA mutant and wild-type branchial arch extracts; enhancer analysis; genetic epistasis (EdnrA mutant mice)","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 1–2 — identified Dlx6 as ET-1-dependent binding factor via protein binding and mutant mouse, multiple orthogonal approaches","pmids":["11711438"],"is_preprint":false},{"year":2010,"finding":"Simultaneous deletion of Dlx5 and Dlx6 in mice reduces tangential migration of Lhx6+ and Mafb+ interneurons to the cortex (associated with reduced CXCR4 expression) and preferentially reduces the number of mature parvalbumin+ interneurons, while Dlx5/6+/- heterozygous mice show spontaneous electrographic seizures and reduced gamma oscillations.","method":"Conditional/constitutive knockout, interneuron transplantation, immunohistochemistry, electrophysiology","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including transplantation assay and electrophysiology, specific cellular phenotype","pmids":["20392955"],"is_preprint":false},{"year":2006,"finding":"Loss-of-function of Dlx5 and Dlx6 in mice causes failure of dorsal otic derivatives (semicircular ducts, utricle, saccule, endolymphatic duct) to form, while otic induction initiates normally; Dlx5/6 influence vestibular cell fates by restricting Pax2 and activating Gbx2 and Bmp4 expression domains.","method":"Double knockout mouse, gene expression analysis (in situ hybridization)","journal":"Genesis (New York, N.Y. : 2000)","confidence":"High","confidence_rationale":"Tier 2 — clean double KO with defined vestibular phenotype and downstream gene changes","pmids":["16900517"],"is_preprint":false},{"year":2011,"finding":"Hand2, a bHLH transcription factor, represses Dlx5 and Dlx6 expression in the distal mandibular arch ectomesenchyme following Dlx5/Dlx6-mediated induction of Hand2, establishing a negative-feedback loop; failure to repress Dlx5/Dlx6 upregulates Runx2, causes aberrant bone formation, and results in aglossia.","method":"Conditional knockout, expression analysis, genetic epistasis","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — epistasis with specific cellular and morphological phenotypes, identifies a feedback loop","pmids":["21558373"],"is_preprint":false},{"year":2006,"finding":"Dlx5 and Dlx6 are functionally redundant positive regulators of chondrogenesis in the limb; limb bud mesenchymal cells from Dlx5/6 null embryos show reduced chondrogenesis, and expression of either gene stimulates chondroblast differentiation. Despite divergent amino- and carboxyl-terminal domains, Dlx5 and Dlx6 have overlapping biological function in chondrogenesis through distinct domain requirements.","method":"Limb bud mesenchymal cell differentiation assay (in vitro), domain deletion/mutation analysis, Dlx5/6 null embryo analysis","journal":"Mechanisms of development","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro differentiation assay plus domain mutagenesis, loss-of-function phenotype","pmids":["17027239"],"is_preprint":false},{"year":2009,"finding":"Dlx5 functions as a cell-autonomous regulator of chondrocyte hypertrophy, demonstrated by chondrocyte-specific Col2a1-Dlx5 transgenic mice showing accelerated hypertrophy and mineralization, and this transgene rescuing Dlx5/6 null chondrocyte differentiation defects. Dlx5 and Dlx6 are functionally equivalent in the endochondral skeleton.","method":"Chondrocyte-specific transgenic overexpression; rescue of Dlx5/6 null phenotype; histological analysis","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — cell-autonomous function established by tissue-specific transgenic rescue","pmids":["19956613"],"is_preprint":false},{"year":2010,"finding":"A single-nucleotide polymorphism (SNP) within the ultraconserved I56i enhancer in the Dlx5/Dlx6 intergenic region reduces Dlx protein binding affinity to their recognition site in vitro, reduces transcriptional activation of the enhancer by Dlx proteins, and decreases I56i enhancer activity predominantly in medial and caudal ganglionic eminences. Additionally, affinity purification using I56i sequences identified GTF2I (general transcription factor 2I) as a novel regulator of Dlx gene expression.","method":"Transgenic reporter assay, in vitro binding assay (affinity purification), transcriptional activation assay","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro binding assay, affinity purification, reporter assay, multiple orthogonal methods","pmids":["20702565"],"is_preprint":false},{"year":2011,"finding":"Dlx6 is required for molecular properties of the striatum and central nucleus of the amygdala; Dlx6 mutants show reduced expression of Golf, RXRγ, Tiam2 in the striatum and reduced Dlx5 in the central nucleus of the amygdala. Unlike other Dlx genes, Dlx6 expression is not readily observed in tangentially migrating interneurons.","method":"Dlx6 null (LacZ knockin) mouse; RNA expression array; immunohistochemistry; in situ hybridization","journal":"The Journal of comparative neurology","confidence":"Medium","confidence_rationale":"Tier 2 — loss-of-function with specific gene expression phenotype in defined brain regions, single lab","pmids":["21452241"],"is_preprint":false},{"year":2011,"finding":"Allelic reduction of Dlx5 and Dlx6 in mice causes a primary ovarian insufficiency (POI)-like phenotype with reduced fertility and early follicular exhaustion; a reciprocal regulation exists between Dlx5 and Foxl2 in granulosa cells, and allelic reduction of Dlx5/6 results in upregulation of Foxl2 in the ovary.","method":"Heterozygous mouse model, granulosa cell line experiments, gene expression analysis","journal":"Human molecular genetics","confidence":"Medium","confidence_rationale":"Tier 2 — partial loss-of-function with reproductive phenotype, identified Foxl2 cross-regulation, single lab","pmids":["21505076"],"is_preprint":false},{"year":2013,"finding":"Dlx5 and Dlx6 regulate a Dlx-Msx regulatory loop involving BMP molecules during limb development: in anterior limb mesoderm, a non-cell autonomous Msx-Dlx regulatory loop involves BMP through the AER; in AER cells Dlx5 and Dlx6 regulate Msx2 cell-autonomously. Triple mutant (Msx1;Dlx5;Dlx6) mice exhibit hallmark anomalies of Msx1;Msx2 double mutants, revealing epistatic roles of Dlx5 and Dlx6 over Msx2.","method":"Triple knockout mice, ChIP, qPCR, bioinformatics, genetic epistasis","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1–2 — triple mutant epistasis, ChIP, multiple orthogonal methods","pmids":["23382810"],"is_preprint":false},{"year":2013,"finding":"Edn1/Ednra signaling regulates neural crest differentiation for pharyngeal arch artery patterning through a Dlx5/Dlx6-independent mechanism; Dlx5/Dlx6 knockout does not significantly affect pharyngeal arch artery or coronary artery development, placing Dlx5/Dlx6 downstream of Edn1/Ednra specifically in jaw identity but not great vessel formation.","method":"Dlx5/Dlx6 knockout mice, Ednra knockout mice, neural crest cell lineage tracing (Wnt1-Cre), immunostaining","journal":"Mechanisms of development","confidence":"High","confidence_rationale":"Tier 2 — genetic epistasis with lineage tracing, multiple mutant models","pmids":["23933587"],"is_preprint":false},{"year":2015,"finding":"Dlx5 and Dlx6 control uterine adenogenesis; conditional inactivation in the endometrium (using Pgr-Cre) results in sterility, very few uterine glands, and reduced expression of Foxa2 and Msx1, establishing Dlx5/Dlx6 as required for uterine gland formation and epithelial remodeling during implantation.","method":"Conditional knockout (Pgr-Cre), histology, gene expression analysis","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — tissue-specific conditional KO with clear reproductive phenotype and downstream gene identification","pmids":["26512061"],"is_preprint":false},{"year":2015,"finding":"In Dlx5/6 double knockout hindlimbs, the apical ectodermal ridge (AER) has reduced Wnt5a expression, scattered β-catenin-responsive cells, and altered cell polarity; exogenous Wnt5a restores AER stratification and marker expression, placing Dlx5/Dlx6 upstream of Wnt5a signaling in AER organization and ectrodactyly.","method":"Double knockout mouse, ex vivo limb culture with Wnt5a addition, gene expression analysis, immunofluorescence","journal":"Human molecular genetics","confidence":"High","confidence_rationale":"Tier 2 — loss-of-function plus rescue experiment with Wnt5a, identifies pathway position","pmids":["26685160"],"is_preprint":false},{"year":2019,"finding":"Dlx5 and Dlx6 expression antagonizes cell proliferation by reducing the proportion of cells in S-phase and affecting cell cycle length in multiple cell types, without inducing apoptosis, suggesting a lineage-independent cell cycle regulatory function at the G1/S checkpoint to facilitate differentiation.","method":"Overexpression in multiple cell lines, cell cycle analysis (BrdU/flow cytometry)","journal":"BMC molecular and cell biology","confidence":"Medium","confidence_rationale":"Tier 2–3 — overexpression in multiple cell types with cell cycle phenotype, single lab","pmids":["31041891"],"is_preprint":false},{"year":2019,"finding":"Conditional inactivation of Dlx5/Dlx6 in all GABAergic interneurons (Vgat-Cre mice) results in reduced anxiety-like behavior, reduced obsessive-compulsive activities, body weight reduction at 20 months (due to loss of adipose tissue), and a 33% longer median survival with improved hallmarks of biological aging.","method":"Conditional knockout (Vgat-Cre), behavioral analysis, metabolic phenotyping, survival analysis","journal":"Aging","confidence":"Medium","confidence_rationale":"Tier 2 — conditional KO with behavioral and metabolic phenotypes, single lab","pmids":["31514171"],"is_preprint":false},{"year":2011,"finding":"Dlx5 and Dlx6 expression in the anterior neural fold (NF-ZA territory) is required for ectethmoid nasal capsule formation; siRNA-mediated downregulation in chick neurula or surgical removal of the NF-ZA territory prevents ectethmoid formation without affecting the mesethmoid, and NF-ZA grafting produces an ectopic ectethmoid.","method":"siRNA knockdown in chick, surgical ablation/grafting, mouse double KO, in situ hybridization","journal":"Development (Cambridge, England)","confidence":"High","confidence_rationale":"Tier 2 — multiple complementary approaches (KO, siRNA, surgery), cross-species validation","pmids":["21270050"],"is_preprint":false},{"year":2019,"finding":"Dlx5/Dlx6 expression at the neural plate border is required for posterior axis formation; Dlx5/6 inactivation in mouse results in open thoracic and lumbar vertebral arches and failure of epaxial muscle formation; zebrafish dlx5a/6a morphants show posterior neural tube defects with altered neural crest cell adhesion molecule expression and motoneuronal development defects.","method":"Mouse double KO, zebrafish morpholino knockdown, neural crest cell analysis, in situ hybridization","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2 — cross-species (mouse and zebrafish) loss-of-function with defined posterior axis phenotype","pmids":["30889190"],"is_preprint":false},{"year":2014,"finding":"A LINE-1 insertion within the DLX6 homeodomain in Nova Scotia Duck Tolling Retrievers introduces a premature stop codon, causing cleft palate, shortened mandible, and tongue displacement phenotypically similar to Pierre Robin sequence, establishing DLX6 loss-of-function as causative for craniofacial defects in this canine model.","method":"Genome-wide association study, sequencing (LINE-1 insertion identification), micro-CT, functional prediction","journal":"PLoS genetics","confidence":"Medium","confidence_rationale":"Tier 3 — genetic mapping plus sequencing identifies causative mutation, functional validation indirect","pmids":["24699068"],"is_preprint":false},{"year":2020,"finding":"DLX6 promotes proliferation and inhibits apoptosis in oral squamous cell carcinoma cells; microarray analysis and Western blotting indicate DLX6 may regulate OSCC cell proliferation through the EGFR-CCND1 axis.","method":"siRNA knockdown in oral cancer cell lines, clone formation, proliferation and apoptosis assays, microarray, Western blot","journal":"Oral diseases","confidence":"Low","confidence_rationale":"Tier 3 — single lab, mechanism inferred from microarray without direct validation of EGFR-CCND1 pathway","pmids":["33215805"],"is_preprint":false},{"year":2023,"finding":"In glioma cells, lncRNA DANCR sponges miR-33b to upregulate DLX6 protein, which in turn transcriptionally activates ATG7 (confirmed by ChIP assay), promoting autophagy and proliferation via the DANCR/miR-33b/DLX6/ATG7 axis.","method":"Dual-luciferase reporter assay, ChIP assay, siRNA knockdown, Western blot, in vivo xenograft","journal":"Oncology reports","confidence":"Medium","confidence_rationale":"Tier 2–3 — ChIP confirms DLX6 binding at ATG7 promoter, multiple orthogonal assays, single lab","pmids":["36601767"],"is_preprint":false},{"year":2020,"finding":"DLX6-AS1 lncRNA forms a triplex structure with the DLX6 gene promoter region via interaction with p300/E2F1 acetyltransferase complex, promoting DLX6 expression and endometrial cancer progression.","method":"Dual-luciferase reporter assay, ChIP, RNA-protein interaction assay, xenograft mouse model","journal":"Journal of cellular and molecular medicine","confidence":"Medium","confidence_rationale":"Tier 2–3 — triplex mechanism supported by ChIP and protein interaction data, single lab","pmids":["32951317"],"is_preprint":false},{"year":2024,"finding":"DLX6-AS1 lncRNA is upregulated by BMP9 in dental pulp cells and promotes odonto/osteogenic differentiation by sponging miR-128-3p, which targets MAPK14; RNA immunoprecipitation and dual luciferase reporter assays confirmed direct interactions between DLX6-AS1, miR-128-3p, and MAPK14.","method":"qRT-PCR, RNA immunoprecipitation, dual luciferase reporter assay, siRNA/overexpression, alkaline phosphatase/alizarin red staining","journal":"International endodontic journal","confidence":"Medium","confidence_rationale":"Tier 2–3 — direct interaction validated by RIP and luciferase, differentiation assay as functional readout, single lab","pmids":["38973098"],"is_preprint":false}],"current_model":"DLX6 encodes a homeodomain transcription factor that, together with its paralog DLX5, functions as a critical regulator of craniofacial, limb, inner ear, uterine, and GABAergic interneuron development by binding homeodomain sites in target enhancers (including the dHAND branchial arch enhancer and Dlx intergenic cross-regulatory enhancers), acting downstream of ET-1/Ednra signaling in jaw patterning, upstream of Wnt5a in apical ectodermal ridge organization, and regulating chondrocyte hypertrophy and chondrogenesis cell-autonomously; additionally, the DLX6 antisense lncRNA DLX6-AS1 acts as a competing endogenous RNA sponge for multiple microRNAs and can recruit epigenetic complexes (p300/E2F1, DNMT1) to regulate target gene expression in various pathological contexts."},"narrative":{"teleology":[{"year":2000,"claim":"Establishing that DLX family members cross-regulate one another through a conserved intergenic enhancer resolved how Dlx5/Dlx6 transcription is controlled in the forebrain and linked Dlx gene regulation to an autoregulatory/cross-regulatory circuit.","evidence":"Transgenic reporter assay, EMSA, cotransfection, Dlx1/Dlx2 double-mutant epistasis in mouse forebrain","pmids":["10632600"],"confidence":"High","gaps":["Whether additional trans-acting factors beyond Dlx1/2 regulate the intergenic enhancer in vivo","Whether the cross-regulatory mechanism operates identically in non-forebrain tissues"]},{"year":2001,"claim":"Identifying DLX6 as a direct downstream effector of ET-1/Ednra signaling that binds the dHAND enhancer placed DLX6 within a signaling cascade governing craniofacial morphogenesis.","evidence":"Protein binding assay comparing wild-type and EdnrA-mutant branchial arch extracts; enhancer analysis in mouse","pmids":["11711438"],"confidence":"High","gaps":["Whether DLX6 binding to the dHAND enhancer is direct or requires co-factors","The complete set of DLX6 direct transcriptional targets in the mandibular arch"]},{"year":2002,"claim":"Double knockout of Dlx5 and Dlx6 revealed their combined essential roles in jaw identity (homeotic mandible-to-maxilla transformation) and limb outgrowth (SHFM phenotype), establishing them as homeotic-like regulators in Hox-free territories.","evidence":"Dlx5/Dlx6 double knockout mice with morphological, histological, and skeletal analysis; transgenic Dlx5 rescue of limb phenotype","pmids":["12000792","12434331"],"confidence":"High","gaps":["The relative individual contributions of Dlx5 versus Dlx6 to each phenotype","Downstream target genes mediating the jaw homeotic transformation"]},{"year":2006,"claim":"Extending the phenotypic spectrum, Dlx5/Dlx6 loss was shown to abolish dorsal otic structures and to positively regulate chondrogenesis with functional redundancy, broadening their roles to inner ear patterning and endochondral skeleton formation.","evidence":"Double KO mouse vestibular phenotype with in situ hybridization; limb bud mesenchymal differentiation assay with domain mutagenesis","pmids":["16900517","17027239"],"confidence":"High","gaps":["Whether DLX5 and DLX6 have distinct domain-specific functions despite overlapping activity","Direct transcriptional targets in otic epithelium"]},{"year":2009,"claim":"Chondrocyte-specific transgenic rescue demonstrated that DLX5/DLX6 drive chondrocyte hypertrophy cell-autonomously, not through indirect paracrine signals.","evidence":"Col2a1-Dlx5 transgenic mice rescuing Dlx5/6-null chondrocyte defects; histological analysis","pmids":["19956613"],"confidence":"High","gaps":["Direct DLX5/6 target genes in hypertrophic chondrocytes","Whether DLX6 alone is sufficient for the cell-autonomous rescue"]},{"year":2010,"claim":"Loss of Dlx5/Dlx6 in GABAergic progenitors was shown to impair tangential migration and maturation of parvalbumin-positive cortical interneurons, with haploinsufficiency causing seizures, connecting DLX5/6 to cortical circuit function.","evidence":"Conditional/constitutive knockout, interneuron transplantation, immunohistochemistry, electrophysiology in mouse","pmids":["20392955"],"confidence":"High","gaps":["Whether DLX6 alone versus DLX5 alone contributes to interneuron migration","Mechanism by which DLX5/6 regulate CXCR4 expression"]},{"year":2010,"claim":"A SNP in the ultraconserved I56i intergenic enhancer was shown to reduce Dlx protein binding and enhancer activity in ganglionic eminences, and affinity purification identified GTF2I as a novel Dlx regulatory partner, linking enhancer variation to potential neurodevelopmental phenotypes.","evidence":"Transgenic reporter, in vitro binding, affinity purification in mouse","pmids":["20702565"],"confidence":"High","gaps":["In vivo significance of the SNP in human neurodevelopmental disease","Whether GTF2I directly interacts with DLX proteins or acts through the enhancer alone"]},{"year":2011,"claim":"Multiple studies in 2011 expanded DLX5/6 functions to a Hand2–Dlx5/6 negative feedback loop in mandible morphogenesis, ectethmoid nasal capsule formation from the anterior neural fold, striatal/amygdalar gene regulation by Dlx6 alone, and ovarian follicle maintenance via reciprocal Dlx5/Foxl2 regulation.","evidence":"Conditional KO and triple-mutant epistasis in mouse mandible; siRNA and grafting in chick neurula; Dlx6-LacZ knockin with expression array; heterozygous mouse ovarian phenotyping","pmids":["21558373","21270050","21452241","21505076"],"confidence":"High","gaps":["Whether DLX6 has unique non-redundant functions in the striatum independent of DLX5","Direct transcriptional targets of DLX5/6 in granulosa cells","Whether the Hand2–Dlx feedback loop operates in human craniofacial development"]},{"year":2013,"claim":"A Dlx–Msx–BMP regulatory loop was delineated in the limb, with DLX5/6 epistatic over Msx2 in AER cells and operating via BMP in limb mesoderm, and Dlx5/6 were shown to be dispensable for Edn1/Ednra-mediated pharyngeal arch artery patterning.","evidence":"Triple mutant (Msx1;Dlx5;Dlx6) mice with ChIP; Dlx5/6 and Ednra KO with neural crest lineage tracing","pmids":["23382810","23933587"],"confidence":"High","gaps":["Complete catalog of DLX5/6-bound cis-regulatory elements in the AER","Whether additional BMP-independent pathways link DLX5/6 to limb patterning"]},{"year":2014,"claim":"A LINE-1 insertion truncating the DLX6 homeodomain was identified as the causative mutation for Pierre Robin–like craniofacial defects in dogs, providing the first direct genetic link between DLX6 coding mutation and a Mendelian-like craniofacial phenotype.","evidence":"GWAS, sequencing, micro-CT in Nova Scotia Duck Tolling Retrievers","pmids":["24699068"],"confidence":"Medium","gaps":["Functional validation by allelic rescue or in vitro assay of the truncated protein","Whether analogous DLX6 mutations exist in human Pierre Robin sequence patients"]},{"year":2015,"claim":"DLX5/6 were positioned upstream of Wnt5a in AER organization and shown to be required for uterine adenogenesis, broadening their developmental regulatory network to Wnt signaling and reproductive tract morphogenesis.","evidence":"Double KO limb analysis with ex vivo Wnt5a rescue; conditional uterine KO (Pgr-Cre) with histology and expression analysis","pmids":["26685160","26512061"],"confidence":"High","gaps":["Whether DLX5/6 directly activate Wnt5a transcription or act through intermediaries","Target genes downstream of DLX5/6 in uterine gland progenitors"]},{"year":2019,"claim":"DLX5/6 were shown to antagonize cell proliferation at the G1/S checkpoint across multiple cell types, and their conditional loss in GABAergic neurons yielded reduced anxiety, lower adiposity, and extended lifespan, revealing systemic metabolic consequences of interneuron-specific DLX5/6 function.","evidence":"Overexpression with BrdU/flow cytometry in multiple cell lines; Vgat-Cre conditional KO with behavioral and metabolic phenotyping","pmids":["31041891","31514171"],"confidence":"Medium","gaps":["Whether the cell cycle effect is direct transcriptional regulation or indirect","The neural circuit mechanism linking GABAergic DLX5/6 loss to metabolic and aging phenotypes","Whether posterior axis defects in Dlx5/6 null mice involve the same cell cycle mechanism"]},{"year":2023,"claim":"DLX6 was identified as a transcriptional activator of ATG7 in glioma via ChIP-validated promoter binding, placing DLX6 in a DANCR/miR-33b/DLX6/ATG7 axis promoting autophagy, extending DLX6's transcriptional targets beyond developmental contexts.","evidence":"ChIP assay, dual-luciferase reporter, siRNA knockdown, xenograft model in glioma cells","pmids":["36601767"],"confidence":"Medium","gaps":["Whether DLX6-dependent ATG7 activation occurs in normal developmental tissues","Genome-wide binding profile of DLX6 in cancer cells"]},{"year":null,"claim":"Key unresolved questions include the genome-wide direct transcriptional targets of DLX6 in developmental and disease contexts, the non-redundant functions of DLX6 versus DLX5, the structural basis for DLX6 homeodomain target specificity, and whether human DLX6 mutations cause Mendelian craniofacial or neurodevelopmental disorders.","evidence":"","pmids":[],"confidence":"Low","gaps":["No genome-wide ChIP-seq for DLX6 in primary developmental tissues","No crystal or cryo-EM structure of DLX6 homeodomain–DNA complex","No confirmed pathogenic DLX6 coding variants in human genetic disease"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[2,3,9,22]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[2,3,6,10,12,22]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[2,3,9,22]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[2,3,10,12,22]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,1,5,7,8,12,15,18]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[3,13,15]}],"complexes":[],"partners":["DLX5","DLX1","DLX2","HAND2","GTF2I","MSX2"],"other_free_text":[]},"mechanistic_narrative":"DLX6 encodes a homeodomain transcription factor that, together with its paralog DLX5, acts as a master regulator of craniofacial patterning, limb morphogenesis, inner ear development, GABAergic interneuron differentiation, and uterine adenogenesis. In the mandibular arch, DLX6 functions downstream of endothelin-1/Ednra signaling to bind homeodomain sites in the dHAND branchial arch enhancer, specifying lower jaw identity—loss of both Dlx5 and Dlx6 transforms the mandible into a maxilla-like structure [PMID:12434331, PMID:11711438]. During limb development, DLX5/DLX6 operate upstream of Wnt5a to organize the apical ectodermal ridge and regulate a Dlx–Msx–BMP feedback loop controlling digit formation, while in endochondral bone they promote chondrocyte hypertrophy cell-autonomously [PMID:26685160, PMID:23382810, PMID:19956613]. DLX5/DLX6 are also required for tangential migration and maturation of parvalbumin-positive cortical interneurons, vestibular morphogenesis, posterior axis patterning, and uterine gland formation, and a loss-of-function LINE-1 insertion in the DLX6 homeodomain causes a Pierre Robin–like craniofacial syndrome in dogs [PMID:20392955, PMID:16900517, PMID:26512061, PMID:24699068]."},"prefetch_data":{"uniprot":{"accession":"P56179","full_name":"Homeobox protein DLX-6","aliases":[],"length_aa":175,"mass_kda":19.7,"function":"","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/P56179/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/DLX6","classification":"Not Classified","n_dependent_lines":6,"n_total_lines":1208,"dependency_fraction":0.004966887417218543},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/DLX6","total_profiled":1310},"omim":[{"mim_id":"603273","title":"TUMOR PROTEIN p63; TP63","url":"https://www.omim.org/entry/603273"},{"mim_id":"602407","title":"HEART- AND NEURAL CREST DERIVATIVES-EXPRESSED 2; HAND2","url":"https://www.omim.org/entry/602407"},{"mim_id":"602115","title":"FIBROBLAST GROWTH FACTOR 10; FGF10","url":"https://www.omim.org/entry/602115"},{"mim_id":"601911","title":"DISTAL-LESS HOMEOBOX 4; DLX4","url":"https://www.omim.org/entry/601911"},{"mim_id":"601285","title":"PROTEASOME 26S SUBUNIT SEM1; SEM1","url":"https://www.omim.org/entry/601285"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nuclear bodies","reliability":"Approved"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":10.2},{"tissue":"testis","ntpm":5.2}],"url":"https://www.proteinatlas.org/search/DLX6"},"hgnc":{"alias_symbol":[],"prev_symbol":[]},"alphafold":{"accession":"P56179","domains":[{"cath_id":"1.10.10.60","chopping":"55-109","consensus_level":"high","plddt":98.1398,"start":55,"end":109}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/P56179","model_url":"https://alphafold.ebi.ac.uk/files/AF-P56179-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-P56179-F1-predicted_aligned_error_v6.png","plddt_mean":68.69},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=DLX6","jax_strain_url":"https://www.jax.org/strain/search?query=DLX6"},"sequence":{"accession":"P56179","fasta_url":"https://rest.uniprot.org/uniprotkb/P56179.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/P56179/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/P56179"}},"corpus_meta":[{"pmid":"12000792","id":"PMC_12000792","title":"The Dlx5 and Dlx6 homeobox genes are essential for craniofacial, axial, and appendicular skeletal development.","date":"2002","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/12000792","citation_count":338,"is_preprint":false},{"pmid":"10632600","id":"PMC_10632600","title":"A highly conserved enhancer in the Dlx5/Dlx6 intergenic region is the site of cross-regulatory interactions between Dlx genes in the embryonic forebrain.","date":"2000","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/10632600","citation_count":276,"is_preprint":false},{"pmid":"12434331","id":"PMC_12434331","title":"Jaw transformation with gain of symmetry after Dlx5/Dlx6 inactivation: mirror of the past?","date":"2002","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/12434331","citation_count":155,"is_preprint":false},{"pmid":"20392955","id":"PMC_20392955","title":"Dlx5 and Dlx6 regulate the development of parvalbumin-expressing cortical interneurons.","date":"2010","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20392955","citation_count":139,"is_preprint":false},{"pmid":"11711438","id":"PMC_11711438","title":"Role of Dlx6 in regulation of an endothelin-1-dependent, dHAND branchial arch enhancer.","date":"2001","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/11711438","citation_count":129,"is_preprint":false},{"pmid":"26052251","id":"PMC_26052251","title":"Expression of long non-coding RNA DLX6-AS1 in lung adenocarcinoma.","date":"2015","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/26052251","citation_count":73,"is_preprint":false},{"pmid":"21558373","id":"PMC_21558373","title":"Downregulation of Dlx5 and Dlx6 expression by Hand2 is essential for initiation of tongue morphogenesis.","date":"2011","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21558373","citation_count":73,"is_preprint":false},{"pmid":"29145165","id":"PMC_29145165","title":"Long non-coding RNA DLX6-AS1 aggravates hepatocellular carcinoma carcinogenesis by modulating miR-203a/MMP-2 pathway.","date":"2017","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/29145165","citation_count":66,"is_preprint":false},{"pmid":"31171015","id":"PMC_31171015","title":"Down-regulated lncRNA DLX6-AS1 inhibits tumorigenesis through STAT3 signaling pathway by suppressing CADM1 promoter methylation in liver cancer stem cells.","date":"2019","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/31171015","citation_count":66,"is_preprint":false},{"pmid":"31463827","id":"PMC_31463827","title":"DLX6-AS1/miR-204-5p/OCT1 positive feedback loop promotes tumor progression and epithelial-mesenchymal transition in gastric cancer.","date":"2019","source":"Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association","url":"https://pubmed.ncbi.nlm.nih.gov/31463827","citation_count":64,"is_preprint":false},{"pmid":"31118816","id":"PMC_31118816","title":"Long noncoding RNA DLX6-AS1 promotes tumorigenesis by modulating miR-497-5p/FZD4/FZD6/Wnt/β-catenin pathway in pancreatic cancer.","date":"2019","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/31118816","citation_count":62,"is_preprint":false},{"pmid":"30442366","id":"PMC_30442366","title":"LncRNA DLX6-AS1/miR-129-5p/DLK1 axis aggravates stemness of osteosarcoma through Wnt signaling.","date":"2018","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/30442366","citation_count":59,"is_preprint":false},{"pmid":"20702565","id":"PMC_20702565","title":"An SNP in an ultraconserved regulatory element affects Dlx5/Dlx6 regulation in the forebrain.","date":"2010","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/20702565","citation_count":58,"is_preprint":false},{"pmid":"28881158","id":"PMC_28881158","title":"Long noncoding RNA DLX6-AS1 promotes renal cell carcinoma progression via miR-26a/PTEN axis.","date":"2017","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/28881158","citation_count":57,"is_preprint":false},{"pmid":"32666494","id":"PMC_32666494","title":"Knockdown of LncRNA DLX6-AS1 inhibits HK-2 cell pyroptosis via regulating miR-223-3p/NLRP3 pathway in lipopolysaccharide-induced acute kidney injury.","date":"2020","source":"Journal of bioenergetics and biomembranes","url":"https://pubmed.ncbi.nlm.nih.gov/32666494","citation_count":57,"is_preprint":false},{"pmid":"30366080","id":"PMC_30366080","title":"Long noncoding RNA DLX6-AS1 accelerates the glioma carcinogenesis by competing endogenous sponging miR-197-5p to relieve E2F1.","date":"2018","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/30366080","citation_count":57,"is_preprint":false},{"pmid":"32686982","id":"PMC_32686982","title":"LncRNA DLX6-AS1 Contributes to Epithelial-Mesenchymal Transition and Cisplatin Resistance in Triple-negative Breast Cancer via Modulating Mir-199b-5p/Paxillin Axis.","date":"2020","source":"Cell transplantation","url":"https://pubmed.ncbi.nlm.nih.gov/32686982","citation_count":50,"is_preprint":false},{"pmid":"31612030","id":"PMC_31612030","title":"Exosomal long non-coding RNA DLX6-AS1 as a potential diagnostic biomarker for non-small cell lung cancer.","date":"2019","source":"Oncology letters","url":"https://pubmed.ncbi.nlm.nih.gov/31612030","citation_count":49,"is_preprint":false},{"pmid":"30805988","id":"PMC_30805988","title":"Long noncoding RNA DLX6-AS1 promotes liver cancer by increasing the expression of WEE1 via targeting miR-424-5p.","date":"2019","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30805988","citation_count":48,"is_preprint":false},{"pmid":"30551440","id":"PMC_30551440","title":"Knockdown of lncRNA DLX6-AS1 inhibits cell proliferation, migration and invasion while promotes apoptosis by downregulating PRR11 expression and upregulating miR-144 in non-small cell lung cancer.","date":"2018","source":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","url":"https://pubmed.ncbi.nlm.nih.gov/30551440","citation_count":47,"is_preprint":false},{"pmid":"16900517","id":"PMC_16900517","title":"Dlx5 and Dlx6 homeobox genes are required for specification of the mammalian vestibular apparatus.","date":"2006","source":"Genesis (New York, N.Y. : 2000)","url":"https://pubmed.ncbi.nlm.nih.gov/16900517","citation_count":45,"is_preprint":false},{"pmid":"30250401","id":"PMC_30250401","title":"LncRNA DLX6-AS1 promoted cancer cell proliferation and invasion by attenuating the endogenous function of miR-181b in pancreatic cancer.","date":"2018","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/30250401","citation_count":44,"is_preprint":false},{"pmid":"24699068","id":"PMC_24699068","title":"A LINE-1 insertion in DLX6 is responsible for cleft palate and mandibular abnormalities in a canine model of Pierre Robin sequence.","date":"2014","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24699068","citation_count":44,"is_preprint":false},{"pmid":"17701895","id":"PMC_17701895","title":"DLX5 and DLX6 expression is biallelic and not modulated by MeCP2 deficiency.","date":"2007","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17701895","citation_count":43,"is_preprint":false},{"pmid":"11180958","id":"PMC_11180958","title":"A zebrafish forebrain-specific zinc finger gene can induce ectopic dlx2 and dlx6 expression.","date":"2001","source":"Developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/11180958","citation_count":43,"is_preprint":false},{"pmid":"15183307","id":"PMC_15183307","title":"Developmental regulation of EVF-1, a novel non-coding RNA transcribed upstream of the mouse Dlx6 gene.","date":"2004","source":"Gene expression patterns : GEP","url":"https://pubmed.ncbi.nlm.nih.gov/15183307","citation_count":42,"is_preprint":false},{"pmid":"31615303","id":"PMC_31615303","title":"Long noncoding RNA DLX6-AS1 promotes cell growth and invasiveness in bladder cancer via modulating the miR-223-HSP90B1 axis.","date":"2019","source":"Cell cycle (Georgetown, Tex.)","url":"https://pubmed.ncbi.nlm.nih.gov/31615303","citation_count":42,"is_preprint":false},{"pmid":"31190891","id":"PMC_31190891","title":"LncRNA DLX6-AS1 promotes the proliferation, invasion, and migration of non-small cell lung cancer cells by targeting the miR-27b-3p/GSPT1 axis.","date":"2019","source":"OncoTargets and therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31190891","citation_count":41,"is_preprint":false},{"pmid":"34039401","id":"PMC_34039401","title":"Exosomal DLX6-AS1 from hepatocellular carcinoma cells induces M2 macrophage polarization to promote migration and invasion in hepatocellular carcinoma through microRNA-15a-5p/CXCL17 axis.","date":"2021","source":"Journal of experimental & clinical cancer research : CR","url":"https://pubmed.ncbi.nlm.nih.gov/34039401","citation_count":41,"is_preprint":false},{"pmid":"31705901","id":"PMC_31705901","title":"Long noncoding RNA DLX6-AS1 promotes breast cancer progression via miR-505-3p/RUNX2 axis.","date":"2019","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/31705901","citation_count":40,"is_preprint":false},{"pmid":"35093327","id":"PMC_35093327","title":"cAMP-response element binding protein mediates podocyte injury in diabetic nephropathy by targeting lncRNA DLX6-AS1.","date":"2022","source":"Metabolism: clinical and experimental","url":"https://pubmed.ncbi.nlm.nih.gov/35093327","citation_count":37,"is_preprint":false},{"pmid":"31514171","id":"PMC_31514171","title":"Dlx5 and Dlx6 expression in GABAergic neurons controls behavior, metabolism, healthy aging and lifespan.","date":"2019","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/31514171","citation_count":36,"is_preprint":false},{"pmid":"19707792","id":"PMC_19707792","title":"Deletion of an enhancer near DLX5 and DLX6 in a family with hearing loss, craniofacial defects, and an inv(7)(q21.3q35).","date":"2010","source":"Human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/19707792","citation_count":36,"is_preprint":false},{"pmid":"31646562","id":"PMC_31646562","title":"The up-regulated lncRNA DLX6-AS1 in colorectal cancer promotes cell proliferation, invasion and migration via modulating PI3K/AKT/mTOR pathway.","date":"2019","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31646562","citation_count":36,"is_preprint":false},{"pmid":"31787849","id":"PMC_31787849","title":"The lncRNA DLX6-AS1 promoted cell proliferation, invasion, migration and epithelial-to-mesenchymal transition in bladder cancer via modulating Wnt/β-catenin signaling pathway.","date":"2019","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/31787849","citation_count":36,"is_preprint":false},{"pmid":"30838699","id":"PMC_30838699","title":"LncRNA DLX6-AS1 promotes tumor proliferation and metastasis in osteosarcoma through modulating miR-641/HOXA9 signaling pathway.","date":"2019","source":"Journal of cellular biochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/30838699","citation_count":35,"is_preprint":false},{"pmid":"32077747","id":"PMC_32077747","title":"Long Noncoding RNA DLX6-AS1 Promotes the Progression in Cervical Cancer by Targeting miR-16-5p/ARPP19 Axis.","date":"2020","source":"Cancer biotherapy & radiopharmaceuticals","url":"https://pubmed.ncbi.nlm.nih.gov/32077747","citation_count":32,"is_preprint":false},{"pmid":"31591939","id":"PMC_31591939","title":"DLX6-AS1 promotes cell proliferation, migration and EMT of gastric cancer through FUS-regulated MAP4K1.","date":"2019","source":"Cancer biology & therapy","url":"https://pubmed.ncbi.nlm.nih.gov/31591939","citation_count":30,"is_preprint":false},{"pmid":"32756011","id":"PMC_32756011","title":"Long non-coding RNA DLX6-AS1 facilitates bladder cancer progression through modulating miR-195-5p/VEGFA signaling pathway.","date":"2020","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/32756011","citation_count":29,"is_preprint":false},{"pmid":"31787850","id":"PMC_31787850","title":"Long noncoding RNA DLX6-AS1 promotes neuroblastoma progression by regulating miR-107/BDNF pathway.","date":"2019","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/31787850","citation_count":29,"is_preprint":false},{"pmid":"21452241","id":"PMC_21452241","title":"Dlx6 regulates molecular properties of the striatum and central nucleus of the amygdala.","date":"2011","source":"The Journal of comparative neurology","url":"https://pubmed.ncbi.nlm.nih.gov/21452241","citation_count":29,"is_preprint":false},{"pmid":"26512061","id":"PMC_26512061","title":"Dlx5 and Dlx6 control uterine adenogenesis during post-natal maturation: possible consequences for endometriosis.","date":"2015","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26512061","citation_count":28,"is_preprint":false},{"pmid":"32774164","id":"PMC_32774164","title":"LncRNA DLX6-AS1 aggravates the development of ovarian cancer via modulating FHL2 by sponging miR-195-5p.","date":"2020","source":"Cancer cell international","url":"https://pubmed.ncbi.nlm.nih.gov/32774164","citation_count":27,"is_preprint":false},{"pmid":"31782911","id":"PMC_31782911","title":"LncRNA DLX6-AS1 increases the expression of HIF-1α and promotes the malignant phenotypes of nasopharyngeal carcinoma cells via targeting MiR-199a-5p.","date":"2019","source":"Molecular genetics & genomic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31782911","citation_count":26,"is_preprint":false},{"pmid":"23382810","id":"PMC_23382810","title":"BMP-mediated functional cooperation between Dlx5;Dlx6 and Msx1;Msx2 during mammalian limb development.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23382810","citation_count":25,"is_preprint":false},{"pmid":"34823630","id":"PMC_34823630","title":"DLX6-AS1: a putative lncRNA candidate in multiple human cancers.","date":"2021","source":"Expert reviews in molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34823630","citation_count":25,"is_preprint":false},{"pmid":"19195802","id":"PMC_19195802","title":"Expression analysis and mutation detection of DLX5 and DLX6 in autism.","date":"2009","source":"Brain & development","url":"https://pubmed.ncbi.nlm.nih.gov/19195802","citation_count":24,"is_preprint":false},{"pmid":"17027239","id":"PMC_17027239","title":"Dlx5- and Dlx6-mediated chondrogenesis: Differential domain requirements for a conserved function.","date":"2006","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/17027239","citation_count":23,"is_preprint":false},{"pmid":"32951317","id":"PMC_32951317","title":"Long non-coding RNA DLX6-AS1 mediates proliferation, invasion and apoptosis of endometrial cancer cells by recruiting p300/E2F1 in DLX6 promoter region.","date":"2020","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32951317","citation_count":23,"is_preprint":false},{"pmid":"32239379","id":"PMC_32239379","title":"DLX6 Antisense RNA 1 Modulates Glucose Metabolism and Cell Growth in Gastric Cancer by Targeting microRNA-4290.","date":"2020","source":"Digestive diseases and sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32239379","citation_count":22,"is_preprint":false},{"pmid":"36854759","id":"PMC_36854759","title":"Long non-coding RNA DLX6-AS1 is the key mediator of glomerular podocyte injury and albuminuria in diabetic nephropathy by targeting the miR-346/GSK-3β signaling pathway.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/36854759","citation_count":22,"is_preprint":false},{"pmid":"30055134","id":"PMC_30055134","title":"Long non-coding RNA DLX6-AS1 is upregulated in preeclampsia and modulates migration and invasion of trophoblasts through the miR-376c/GADD45A axis.","date":"2018","source":"Experimental cell research","url":"https://pubmed.ncbi.nlm.nih.gov/30055134","citation_count":22,"is_preprint":false},{"pmid":"25332435","id":"PMC_25332435","title":"Absent expression of the osteoblast-specific maternally imprinted genes, DLX5 and DLX6, causes split hand/split foot malformation type I.","date":"2014","source":"Journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25332435","citation_count":21,"is_preprint":false},{"pmid":"32368147","id":"PMC_32368147","title":"lncRNA DLX6-AS1 Promotes Proliferation of Laryngeal Cancer Cells by Targeting the miR-26a/TRPC3 Pathway.","date":"2020","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/32368147","citation_count":21,"is_preprint":false},{"pmid":"33277615","id":"PMC_33277615","title":"Upregulated lncRNA DLX6-AS1 underpins hepatocellular carcinoma progression via the miR-513c/Cul4A/ANXA10 axis.","date":"2020","source":"Cancer gene therapy","url":"https://pubmed.ncbi.nlm.nih.gov/33277615","citation_count":20,"is_preprint":false},{"pmid":"31105791","id":"PMC_31105791","title":"Long non-coding RNA DLX6-AS1 silencing inhibits malignant phenotypes of gastric cancer cells.","date":"2019","source":"Experimental and therapeutic medicine","url":"https://pubmed.ncbi.nlm.nih.gov/31105791","citation_count":20,"is_preprint":false},{"pmid":"19956613","id":"PMC_19956613","title":"Dlx5 Is a cell autonomous regulator of chondrocyte hypertrophy in mice and functionally substitutes for Dlx6 during endochondral ossification.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19956613","citation_count":20,"is_preprint":false},{"pmid":"28611547","id":"PMC_28611547","title":"A Novel Heterozygous Intragenic Sequence Variant in DLX6 Probably Underlies First Case of Autosomal Dominant Split-Hand/Foot Malformation Type 1.","date":"2016","source":"Molecular syndromology","url":"https://pubmed.ncbi.nlm.nih.gov/28611547","citation_count":20,"is_preprint":false},{"pmid":"32904436","id":"PMC_32904436","title":"LncRNA DLX6-AS1 Promotes the Progression of Neuroblastoma by Activating STAT2 via Targeting miR-506-3p.","date":"2020","source":"Cancer management and research","url":"https://pubmed.ncbi.nlm.nih.gov/32904436","citation_count":20,"is_preprint":false},{"pmid":"33216728","id":"PMC_33216728","title":"Protective effect of DLX6-AS1 silencing against cerebral ischemia/reperfusion induced impairments.","date":"2020","source":"Aging","url":"https://pubmed.ncbi.nlm.nih.gov/33216728","citation_count":19,"is_preprint":false},{"pmid":"31814904","id":"PMC_31814904","title":"LncRNA DLX6-AS1 promotes laryngeal squamous cell carcinoma growth and invasion through regulating miR-376c.","date":"2019","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/31814904","citation_count":18,"is_preprint":false},{"pmid":"34697393","id":"PMC_34697393","title":"DLX6-AS1 activated by H3K4me1 enhanced secondary cisplatin resistance of lung squamous cell carcinoma through modulating miR-181a-5p/miR-382-5p/CELF1 axis.","date":"2021","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/34697393","citation_count":18,"is_preprint":false},{"pmid":"32250737","id":"PMC_32250737","title":"The regulatory network of lncRNA DLX6-AS1/miR-149-5p/ERP44 is possibly related to the progression of preeclampsia.","date":"2020","source":"Placenta","url":"https://pubmed.ncbi.nlm.nih.gov/32250737","citation_count":17,"is_preprint":false},{"pmid":"30535431","id":"PMC_30535431","title":"Long non‑coding RNA DLX6‑AS1 promotes proliferation by acting as a ceRNA targeting miR‑199a in cervical cancer.","date":"2018","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/30535431","citation_count":17,"is_preprint":false},{"pmid":"22342398","id":"PMC_22342398","title":"Rapp-Hodgkin syndrome and SHFM1 patients: delineating the p63-Dlx5/Dlx6 pathway.","date":"2012","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/22342398","citation_count":17,"is_preprint":false},{"pmid":"23933587","id":"PMC_23933587","title":"Endothelin regulates neural crest deployment and fate to form great vessels through Dlx5/Dlx6-independent mechanisms.","date":"2013","source":"Mechanisms of development","url":"https://pubmed.ncbi.nlm.nih.gov/23933587","citation_count":17,"is_preprint":false},{"pmid":"21505076","id":"PMC_21505076","title":"Allelic reduction of Dlx5 and Dlx6 results in early follicular depletion: a new mouse model of primary ovarian insufficiency.","date":"2011","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/21505076","citation_count":17,"is_preprint":false},{"pmid":"35550840","id":"PMC_35550840","title":"LncRNA DLX6-AS1 promotes microglial inflammatory response in Parkinson's disease by regulating the miR-223-3p/NRP1 axis.","date":"2022","source":"Behavioural brain research","url":"https://pubmed.ncbi.nlm.nih.gov/35550840","citation_count":17,"is_preprint":false},{"pmid":"30592268","id":"PMC_30592268","title":"Long non‑coding RNA DLX6‑AS1 is associated with malignant progression and promotes proliferation and invasion in esophageal squamous cell carcinoma.","date":"2018","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/30592268","citation_count":17,"is_preprint":false},{"pmid":"32289431","id":"PMC_32289431","title":"RETRACTED: Long non-coding RNA DLX6-AS1 regulates neuroblastoma progression by targeting YAP1 via miR-497-5p.","date":"2020","source":"Life sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32289431","citation_count":16,"is_preprint":false},{"pmid":"32850336","id":"PMC_32850336","title":"LncRNA DLX6-AS1 Promotes Malignant Phenotype and Lymph Node Metastasis in Prostate Cancer by Inducing LARGE Methylation.","date":"2020","source":"Frontiers in oncology","url":"https://pubmed.ncbi.nlm.nih.gov/32850336","citation_count":16,"is_preprint":false},{"pmid":"36017915","id":"PMC_36017915","title":"A Peptide Encoded by a Long Non-Coding RNA DLX6-AS1 Facilitates Cell Proliferation, Migration, and Invasion by Activating the wnt/β-Catenin Signaling Pathway in Non-Small-Cell Lung Cancer Cell.","date":"2022","source":"Critical reviews in eukaryotic gene expression","url":"https://pubmed.ncbi.nlm.nih.gov/36017915","citation_count":16,"is_preprint":false},{"pmid":"33059027","id":"PMC_33059027","title":"Crosstalk between long non-coding RNA DLX6-AS1, microRNAs and signaling pathways: A pivotal molecular mechanism in human cancers.","date":"2020","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/33059027","citation_count":15,"is_preprint":false},{"pmid":"31378881","id":"PMC_31378881","title":"Long non-coding RNA DLX6-AS1 acts as an oncogene by targeting miR-613 in ovarian cancer.","date":"2019","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31378881","citation_count":15,"is_preprint":false},{"pmid":"26685160","id":"PMC_26685160","title":"The apical ectodermal ridge of the mouse model of ectrodactyly Dlx5;Dlx6-/- shows altered stratification and cell polarity, which are restored by exogenous Wnt5a ligand.","date":"2015","source":"Human molecular genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26685160","citation_count":15,"is_preprint":false},{"pmid":"33215805","id":"PMC_33215805","title":"DLX6 promotes cell proliferation and survival in oral squamous cell carcinoma.","date":"2020","source":"Oral diseases","url":"https://pubmed.ncbi.nlm.nih.gov/33215805","citation_count":15,"is_preprint":false},{"pmid":"34514705","id":"PMC_34514705","title":"Silencing long non-coding RNA DLX6-AS1 or restoring microRNA-193b-3p enhances thyroid carcinoma cell autophagy and apoptosis via depressing HOXA1.","date":"2021","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/34514705","citation_count":15,"is_preprint":false},{"pmid":"31737208","id":"PMC_31737208","title":"Long noncoding RNA DLX6-AS1 targets miR-124-3p/CDK4 to accelerate Ewing's sarcoma.","date":"2019","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/31737208","citation_count":14,"is_preprint":false},{"pmid":"32379493","id":"PMC_32379493","title":"Long Noncoding RNA DLX6-AS1 Regulates the Growth and Aggressiveness of Colorectal Cancer Cells Via Mediating the miR-26a/EZH2 Axis.","date":"2020","source":"Cancer biotherapy & radiopharmaceuticals","url":"https://pubmed.ncbi.nlm.nih.gov/32379493","citation_count":14,"is_preprint":false},{"pmid":"33031637","id":"PMC_33031637","title":"Silencing of long non-coding RNA DLX6-AS1 weakens neuroblastoma progression by the miR-513c-5p/PLK4 axis.","date":"2020","source":"IUBMB life","url":"https://pubmed.ncbi.nlm.nih.gov/33031637","citation_count":14,"is_preprint":false},{"pmid":"33035382","id":"PMC_33035382","title":"DLX6-AS1 accelerates cell proliferation through regulating miR-497-5p/SNCG pathway in prostate cancer.","date":"2020","source":"Environmental toxicology","url":"https://pubmed.ncbi.nlm.nih.gov/33035382","citation_count":13,"is_preprint":false},{"pmid":"35281110","id":"PMC_35281110","title":"DLX6-AS1: A Long Non-coding RNA With Oncogenic Features.","date":"2022","source":"Frontiers in cell and developmental biology","url":"https://pubmed.ncbi.nlm.nih.gov/35281110","citation_count":13,"is_preprint":false},{"pmid":"11351265","id":"PMC_11351265","title":"The coding region of the human DLX6 gene contains a polymorphic CAG/CCG repeat.","date":"2001","source":"International journal of oncology","url":"https://pubmed.ncbi.nlm.nih.gov/11351265","citation_count":13,"is_preprint":false},{"pmid":"31539117","id":"PMC_31539117","title":"Knockdown of long noncoding RNA DLX6-AS1 inhibits cell proliferation and invasion of cervical cancer cells by downregulating FUS.","date":"2019","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31539117","citation_count":13,"is_preprint":false},{"pmid":"36601767","id":"PMC_36601767","title":"DANCR promotes glioma cell autophagy and proliferation via the miR‑33b/DLX6/ATG7 axis.","date":"2023","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/36601767","citation_count":12,"is_preprint":false},{"pmid":"12707945","id":"PMC_12707945","title":"No association between single nucleotide polymorphisms in DLX6 and Piccolo genes at 7q21-q22 and autism.","date":"2003","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/12707945","citation_count":12,"is_preprint":false},{"pmid":"33607068","id":"PMC_33607068","title":"DLX6-AS1 is a potential biomarker and therapeutic target in cancer initiation and progression.","date":"2021","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/33607068","citation_count":11,"is_preprint":false},{"pmid":"21270050","id":"PMC_21270050","title":"Dlx5 and Dlx6 expression in the anterior neural fold is essential for patterning the dorsal nasal capsule.","date":"2011","source":"Development (Cambridge, England)","url":"https://pubmed.ncbi.nlm.nih.gov/21270050","citation_count":11,"is_preprint":false},{"pmid":"31115000","id":"PMC_31115000","title":"Long noncoding RNA DLX6-AS1 functions as a competing endogenous RNA for miR-577 to promote malignant development of colorectal cancer.","date":"2019","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31115000","citation_count":11,"is_preprint":false},{"pmid":"36660176","id":"PMC_36660176","title":"lncRNA DLX6-AS1 Promotes Myocardial Ischemia-Reperfusion Injury through Mediating the miR-204-5p/FBXW7 Axis.","date":"2023","source":"Mediators of inflammation","url":"https://pubmed.ncbi.nlm.nih.gov/36660176","citation_count":11,"is_preprint":false},{"pmid":"35116677","id":"PMC_35116677","title":"Long non-coding RNA DLX6-AS1 knockdown suppresses the tumorigenesis and progression of non-small cell lung cancer through microRNA-16-5p/BMI1 axis.","date":"2021","source":"Translational cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/35116677","citation_count":10,"is_preprint":false},{"pmid":"37767112","id":"PMC_37767112","title":"The lncRNA DLX6-AS1/miR-16-5p axis regulates autophagy and apoptosis in non-small cell lung cancer: A Boolean model of cell death.","date":"2023","source":"Non-coding RNA research","url":"https://pubmed.ncbi.nlm.nih.gov/37767112","citation_count":10,"is_preprint":false},{"pmid":"33121401","id":"PMC_33121401","title":"DLX6-AS1: An Indispensable Cancer-related Long Non-coding RNA.","date":"2021","source":"Current pharmaceutical design","url":"https://pubmed.ncbi.nlm.nih.gov/33121401","citation_count":9,"is_preprint":false},{"pmid":"33437353","id":"PMC_33437353","title":"Promising long noncoding RNA DLX6-AS1 in malignant tumors.","date":"2020","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/33437353","citation_count":9,"is_preprint":false},{"pmid":"38973098","id":"PMC_38973098","title":"DLX6-AS1 regulates odonto/osteogenic differentiation in dental pulp cells under the control of BMP9 via the miR-128-3p/MAPK14 axis: A laboratory investigation.","date":"2024","source":"International endodontic journal","url":"https://pubmed.ncbi.nlm.nih.gov/38973098","citation_count":9,"is_preprint":false},{"pmid":"31041891","id":"PMC_31041891","title":"Dlx5 and Dlx6 can antagonize cell division at the G1/S checkpoint.","date":"2019","source":"BMC molecular and cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/31041891","citation_count":8,"is_preprint":false},{"pmid":"34508305","id":"PMC_34508305","title":"Research progress of DLX6-AS1 in human cancers.","date":"2021","source":"Human cell","url":"https://pubmed.ncbi.nlm.nih.gov/34508305","citation_count":7,"is_preprint":false},{"pmid":"32096208","id":"PMC_32096208","title":"Upregulation of long noncoding RNA DLX6-AS1 promotes cell growth and metastasis in esophageal squamous cell carcinoma via targeting miR-577.","date":"2020","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/32096208","citation_count":7,"is_preprint":false},{"pmid":"30889190","id":"PMC_30889190","title":"Posterior axis formation requires Dlx5/Dlx6 expression at the neural plate border.","date":"2019","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/30889190","citation_count":6,"is_preprint":false},{"pmid":"31858555","id":"PMC_31858555","title":"Knockdown of long noncoding RNA DLX6-AS1 inhibits migration and invasion of thyroid cancer cells by upregulating UPF1.","date":"2019","source":"European review for medical and pharmacological sciences","url":"https://pubmed.ncbi.nlm.nih.gov/31858555","citation_count":6,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":52742,"output_tokens":5870,"usd":0.123138},"stage2":{"model":"claude-opus-4-6","input_tokens":9474,"output_tokens":3675,"usd":0.208868},"total_usd":0.332006,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"Combined targeted inactivation of Dlx5 and Dlx6 in mice results in severe craniofacial, axial, and appendicular skeletal abnormalities phenocopying split-hand/split-foot malformation (SHFM), and transgenic overexpression of Dlx5 in the apical ectodermal ridge of Dlx5/6 null mice fully rescues limb outgrowth, establishing Dlx5/Dlx6 as critical regulators of mammalian limb development.\",\n      \"method\": \"Targeted gene knockout (loss-of-function) and transgenic rescue in mice\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — clean KO with specific skeletal phenotype plus transgenic rescue, strong evidence\",\n      \"pmids\": [\"12000792\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"Simultaneous inactivation of Dlx5 and Dlx6 in mice transforms the lower jaw into an upper jaw structure, constituting a homeotic-like transformation in the Hox-free mandibular arch, establishing Dlx5/Dlx6 as homeotic regulators of jaw identity.\",\n      \"method\": \"Double knockout mouse; morphological and histological analysis\",\n      \"journal\": \"Genesis (New York, N.Y. : 2000)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean double KO with defined jaw homeotic phenotype\",\n      \"pmids\": [\"12434331\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2000,\n      \"finding\": \"Dlx1 and Dlx2 proteins bind conserved homeodomain binding sites in the Dlx5/Dlx6 intergenic enhancer region to cross-regulate Dlx5 and Dlx6 expression in the developing forebrain; reporter transgene activity is drastically reduced in Dlx1/Dlx2 double mutants, and Dlx protein binding to the enhancer was confirmed by cotransfection and DNA-protein binding experiments.\",\n      \"method\": \"Transgenic reporter assay, cotransfection, DNA-protein binding (EMSA/binding assay), double-mutant epistasis\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods (reporter, binding assay, genetic epistasis), replicated across mouse and zebrafish\",\n      \"pmids\": [\"10632600\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"Dlx6 protein binds to four homeodomain binding sites in the dHAND branchial arch enhancer in an endothelin-1 (ET-1)/endothelin receptor A (EdnrA)-dependent manner, linking ET-1 signaling to dHAND transcription during craniofacial morphogenesis; Dlx6 expression is down-regulated in EdnrA mutant branchial arches.\",\n      \"method\": \"Protein binding comparison between EdnrA mutant and wild-type branchial arch extracts; enhancer analysis; genetic epistasis (EdnrA mutant mice)\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — identified Dlx6 as ET-1-dependent binding factor via protein binding and mutant mouse, multiple orthogonal approaches\",\n      \"pmids\": [\"11711438\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Simultaneous deletion of Dlx5 and Dlx6 in mice reduces tangential migration of Lhx6+ and Mafb+ interneurons to the cortex (associated with reduced CXCR4 expression) and preferentially reduces the number of mature parvalbumin+ interneurons, while Dlx5/6+/- heterozygous mice show spontaneous electrographic seizures and reduced gamma oscillations.\",\n      \"method\": \"Conditional/constitutive knockout, interneuron transplantation, immunohistochemistry, electrophysiology\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including transplantation assay and electrophysiology, specific cellular phenotype\",\n      \"pmids\": [\"20392955\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Loss-of-function of Dlx5 and Dlx6 in mice causes failure of dorsal otic derivatives (semicircular ducts, utricle, saccule, endolymphatic duct) to form, while otic induction initiates normally; Dlx5/6 influence vestibular cell fates by restricting Pax2 and activating Gbx2 and Bmp4 expression domains.\",\n      \"method\": \"Double knockout mouse, gene expression analysis (in situ hybridization)\",\n      \"journal\": \"Genesis (New York, N.Y. : 2000)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean double KO with defined vestibular phenotype and downstream gene changes\",\n      \"pmids\": [\"16900517\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Hand2, a bHLH transcription factor, represses Dlx5 and Dlx6 expression in the distal mandibular arch ectomesenchyme following Dlx5/Dlx6-mediated induction of Hand2, establishing a negative-feedback loop; failure to repress Dlx5/Dlx6 upregulates Runx2, causes aberrant bone formation, and results in aglossia.\",\n      \"method\": \"Conditional knockout, expression analysis, genetic epistasis\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — epistasis with specific cellular and morphological phenotypes, identifies a feedback loop\",\n      \"pmids\": [\"21558373\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Dlx5 and Dlx6 are functionally redundant positive regulators of chondrogenesis in the limb; limb bud mesenchymal cells from Dlx5/6 null embryos show reduced chondrogenesis, and expression of either gene stimulates chondroblast differentiation. Despite divergent amino- and carboxyl-terminal domains, Dlx5 and Dlx6 have overlapping biological function in chondrogenesis through distinct domain requirements.\",\n      \"method\": \"Limb bud mesenchymal cell differentiation assay (in vitro), domain deletion/mutation analysis, Dlx5/6 null embryo analysis\",\n      \"journal\": \"Mechanisms of development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro differentiation assay plus domain mutagenesis, loss-of-function phenotype\",\n      \"pmids\": [\"17027239\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Dlx5 functions as a cell-autonomous regulator of chondrocyte hypertrophy, demonstrated by chondrocyte-specific Col2a1-Dlx5 transgenic mice showing accelerated hypertrophy and mineralization, and this transgene rescuing Dlx5/6 null chondrocyte differentiation defects. Dlx5 and Dlx6 are functionally equivalent in the endochondral skeleton.\",\n      \"method\": \"Chondrocyte-specific transgenic overexpression; rescue of Dlx5/6 null phenotype; histological analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — cell-autonomous function established by tissue-specific transgenic rescue\",\n      \"pmids\": [\"19956613\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"A single-nucleotide polymorphism (SNP) within the ultraconserved I56i enhancer in the Dlx5/Dlx6 intergenic region reduces Dlx protein binding affinity to their recognition site in vitro, reduces transcriptional activation of the enhancer by Dlx proteins, and decreases I56i enhancer activity predominantly in medial and caudal ganglionic eminences. Additionally, affinity purification using I56i sequences identified GTF2I (general transcription factor 2I) as a novel regulator of Dlx gene expression.\",\n      \"method\": \"Transgenic reporter assay, in vitro binding assay (affinity purification), transcriptional activation assay\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro binding assay, affinity purification, reporter assay, multiple orthogonal methods\",\n      \"pmids\": [\"20702565\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Dlx6 is required for molecular properties of the striatum and central nucleus of the amygdala; Dlx6 mutants show reduced expression of Golf, RXRγ, Tiam2 in the striatum and reduced Dlx5 in the central nucleus of the amygdala. Unlike other Dlx genes, Dlx6 expression is not readily observed in tangentially migrating interneurons.\",\n      \"method\": \"Dlx6 null (LacZ knockin) mouse; RNA expression array; immunohistochemistry; in situ hybridization\",\n      \"journal\": \"The Journal of comparative neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function with specific gene expression phenotype in defined brain regions, single lab\",\n      \"pmids\": [\"21452241\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Allelic reduction of Dlx5 and Dlx6 in mice causes a primary ovarian insufficiency (POI)-like phenotype with reduced fertility and early follicular exhaustion; a reciprocal regulation exists between Dlx5 and Foxl2 in granulosa cells, and allelic reduction of Dlx5/6 results in upregulation of Foxl2 in the ovary.\",\n      \"method\": \"Heterozygous mouse model, granulosa cell line experiments, gene expression analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — partial loss-of-function with reproductive phenotype, identified Foxl2 cross-regulation, single lab\",\n      \"pmids\": [\"21505076\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Dlx5 and Dlx6 regulate a Dlx-Msx regulatory loop involving BMP molecules during limb development: in anterior limb mesoderm, a non-cell autonomous Msx-Dlx regulatory loop involves BMP through the AER; in AER cells Dlx5 and Dlx6 regulate Msx2 cell-autonomously. Triple mutant (Msx1;Dlx5;Dlx6) mice exhibit hallmark anomalies of Msx1;Msx2 double mutants, revealing epistatic roles of Dlx5 and Dlx6 over Msx2.\",\n      \"method\": \"Triple knockout mice, ChIP, qPCR, bioinformatics, genetic epistasis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — triple mutant epistasis, ChIP, multiple orthogonal methods\",\n      \"pmids\": [\"23382810\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Edn1/Ednra signaling regulates neural crest differentiation for pharyngeal arch artery patterning through a Dlx5/Dlx6-independent mechanism; Dlx5/Dlx6 knockout does not significantly affect pharyngeal arch artery or coronary artery development, placing Dlx5/Dlx6 downstream of Edn1/Ednra specifically in jaw identity but not great vessel formation.\",\n      \"method\": \"Dlx5/Dlx6 knockout mice, Ednra knockout mice, neural crest cell lineage tracing (Wnt1-Cre), immunostaining\",\n      \"journal\": \"Mechanisms of development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis with lineage tracing, multiple mutant models\",\n      \"pmids\": [\"23933587\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Dlx5 and Dlx6 control uterine adenogenesis; conditional inactivation in the endometrium (using Pgr-Cre) results in sterility, very few uterine glands, and reduced expression of Foxa2 and Msx1, establishing Dlx5/Dlx6 as required for uterine gland formation and epithelial remodeling during implantation.\",\n      \"method\": \"Conditional knockout (Pgr-Cre), histology, gene expression analysis\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — tissue-specific conditional KO with clear reproductive phenotype and downstream gene identification\",\n      \"pmids\": [\"26512061\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"In Dlx5/6 double knockout hindlimbs, the apical ectodermal ridge (AER) has reduced Wnt5a expression, scattered β-catenin-responsive cells, and altered cell polarity; exogenous Wnt5a restores AER stratification and marker expression, placing Dlx5/Dlx6 upstream of Wnt5a signaling in AER organization and ectrodactyly.\",\n      \"method\": \"Double knockout mouse, ex vivo limb culture with Wnt5a addition, gene expression analysis, immunofluorescence\",\n      \"journal\": \"Human molecular genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — loss-of-function plus rescue experiment with Wnt5a, identifies pathway position\",\n      \"pmids\": [\"26685160\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Dlx5 and Dlx6 expression antagonizes cell proliferation by reducing the proportion of cells in S-phase and affecting cell cycle length in multiple cell types, without inducing apoptosis, suggesting a lineage-independent cell cycle regulatory function at the G1/S checkpoint to facilitate differentiation.\",\n      \"method\": \"Overexpression in multiple cell lines, cell cycle analysis (BrdU/flow cytometry)\",\n      \"journal\": \"BMC molecular and cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — overexpression in multiple cell types with cell cycle phenotype, single lab\",\n      \"pmids\": [\"31041891\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Conditional inactivation of Dlx5/Dlx6 in all GABAergic interneurons (Vgat-Cre mice) results in reduced anxiety-like behavior, reduced obsessive-compulsive activities, body weight reduction at 20 months (due to loss of adipose tissue), and a 33% longer median survival with improved hallmarks of biological aging.\",\n      \"method\": \"Conditional knockout (Vgat-Cre), behavioral analysis, metabolic phenotyping, survival analysis\",\n      \"journal\": \"Aging\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with behavioral and metabolic phenotypes, single lab\",\n      \"pmids\": [\"31514171\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"Dlx5 and Dlx6 expression in the anterior neural fold (NF-ZA territory) is required for ectethmoid nasal capsule formation; siRNA-mediated downregulation in chick neurula or surgical removal of the NF-ZA territory prevents ectethmoid formation without affecting the mesethmoid, and NF-ZA grafting produces an ectopic ectethmoid.\",\n      \"method\": \"siRNA knockdown in chick, surgical ablation/grafting, mouse double KO, in situ hybridization\",\n      \"journal\": \"Development (Cambridge, England)\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple complementary approaches (KO, siRNA, surgery), cross-species validation\",\n      \"pmids\": [\"21270050\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Dlx5/Dlx6 expression at the neural plate border is required for posterior axis formation; Dlx5/6 inactivation in mouse results in open thoracic and lumbar vertebral arches and failure of epaxial muscle formation; zebrafish dlx5a/6a morphants show posterior neural tube defects with altered neural crest cell adhesion molecule expression and motoneuronal development defects.\",\n      \"method\": \"Mouse double KO, zebrafish morpholino knockdown, neural crest cell analysis, in situ hybridization\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — cross-species (mouse and zebrafish) loss-of-function with defined posterior axis phenotype\",\n      \"pmids\": [\"30889190\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"A LINE-1 insertion within the DLX6 homeodomain in Nova Scotia Duck Tolling Retrievers introduces a premature stop codon, causing cleft palate, shortened mandible, and tongue displacement phenotypically similar to Pierre Robin sequence, establishing DLX6 loss-of-function as causative for craniofacial defects in this canine model.\",\n      \"method\": \"Genome-wide association study, sequencing (LINE-1 insertion identification), micro-CT, functional prediction\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — genetic mapping plus sequencing identifies causative mutation, functional validation indirect\",\n      \"pmids\": [\"24699068\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DLX6 promotes proliferation and inhibits apoptosis in oral squamous cell carcinoma cells; microarray analysis and Western blotting indicate DLX6 may regulate OSCC cell proliferation through the EGFR-CCND1 axis.\",\n      \"method\": \"siRNA knockdown in oral cancer cell lines, clone formation, proliferation and apoptosis assays, microarray, Western blot\",\n      \"journal\": \"Oral diseases\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single lab, mechanism inferred from microarray without direct validation of EGFR-CCND1 pathway\",\n      \"pmids\": [\"33215805\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"In glioma cells, lncRNA DANCR sponges miR-33b to upregulate DLX6 protein, which in turn transcriptionally activates ATG7 (confirmed by ChIP assay), promoting autophagy and proliferation via the DANCR/miR-33b/DLX6/ATG7 axis.\",\n      \"method\": \"Dual-luciferase reporter assay, ChIP assay, siRNA knockdown, Western blot, in vivo xenograft\",\n      \"journal\": \"Oncology reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — ChIP confirms DLX6 binding at ATG7 promoter, multiple orthogonal assays, single lab\",\n      \"pmids\": [\"36601767\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"DLX6-AS1 lncRNA forms a triplex structure with the DLX6 gene promoter region via interaction with p300/E2F1 acetyltransferase complex, promoting DLX6 expression and endometrial cancer progression.\",\n      \"method\": \"Dual-luciferase reporter assay, ChIP, RNA-protein interaction assay, xenograft mouse model\",\n      \"journal\": \"Journal of cellular and molecular medicine\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — triplex mechanism supported by ChIP and protein interaction data, single lab\",\n      \"pmids\": [\"32951317\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"DLX6-AS1 lncRNA is upregulated by BMP9 in dental pulp cells and promotes odonto/osteogenic differentiation by sponging miR-128-3p, which targets MAPK14; RNA immunoprecipitation and dual luciferase reporter assays confirmed direct interactions between DLX6-AS1, miR-128-3p, and MAPK14.\",\n      \"method\": \"qRT-PCR, RNA immunoprecipitation, dual luciferase reporter assay, siRNA/overexpression, alkaline phosphatase/alizarin red staining\",\n      \"journal\": \"International endodontic journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — direct interaction validated by RIP and luciferase, differentiation assay as functional readout, single lab\",\n      \"pmids\": [\"38973098\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"DLX6 encodes a homeodomain transcription factor that, together with its paralog DLX5, functions as a critical regulator of craniofacial, limb, inner ear, uterine, and GABAergic interneuron development by binding homeodomain sites in target enhancers (including the dHAND branchial arch enhancer and Dlx intergenic cross-regulatory enhancers), acting downstream of ET-1/Ednra signaling in jaw patterning, upstream of Wnt5a in apical ectodermal ridge organization, and regulating chondrocyte hypertrophy and chondrogenesis cell-autonomously; additionally, the DLX6 antisense lncRNA DLX6-AS1 acts as a competing endogenous RNA sponge for multiple microRNAs and can recruit epigenetic complexes (p300/E2F1, DNMT1) to regulate target gene expression in various pathological contexts.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"DLX6 encodes a homeodomain transcription factor that, together with its paralog DLX5, acts as a master regulator of craniofacial patterning, limb morphogenesis, inner ear development, GABAergic interneuron differentiation, and uterine adenogenesis. In the mandibular arch, DLX6 functions downstream of endothelin-1/Ednra signaling to bind homeodomain sites in the dHAND branchial arch enhancer, specifying lower jaw identity—loss of both Dlx5 and Dlx6 transforms the mandible into a maxilla-like structure [PMID:12434331, PMID:11711438]. During limb development, DLX5/DLX6 operate upstream of Wnt5a to organize the apical ectodermal ridge and regulate a Dlx–Msx–BMP feedback loop controlling digit formation, while in endochondral bone they promote chondrocyte hypertrophy cell-autonomously [PMID:26685160, PMID:23382810, PMID:19956613]. DLX5/DLX6 are also required for tangential migration and maturation of parvalbumin-positive cortical interneurons, vestibular morphogenesis, posterior axis patterning, and uterine gland formation, and a loss-of-function LINE-1 insertion in the DLX6 homeodomain causes a Pierre Robin–like craniofacial syndrome in dogs [PMID:20392955, PMID:16900517, PMID:26512061, PMID:24699068].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Establishing that DLX family members cross-regulate one another through a conserved intergenic enhancer resolved how Dlx5/Dlx6 transcription is controlled in the forebrain and linked Dlx gene regulation to an autoregulatory/cross-regulatory circuit.\",\n      \"evidence\": \"Transgenic reporter assay, EMSA, cotransfection, Dlx1/Dlx2 double-mutant epistasis in mouse forebrain\",\n      \"pmids\": [\"10632600\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether additional trans-acting factors beyond Dlx1/2 regulate the intergenic enhancer in vivo\",\n        \"Whether the cross-regulatory mechanism operates identically in non-forebrain tissues\"\n      ]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"Identifying DLX6 as a direct downstream effector of ET-1/Ednra signaling that binds the dHAND enhancer placed DLX6 within a signaling cascade governing craniofacial morphogenesis.\",\n      \"evidence\": \"Protein binding assay comparing wild-type and EdnrA-mutant branchial arch extracts; enhancer analysis in mouse\",\n      \"pmids\": [\"11711438\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether DLX6 binding to the dHAND enhancer is direct or requires co-factors\",\n        \"The complete set of DLX6 direct transcriptional targets in the mandibular arch\"\n      ]\n    },\n    {\n      \"year\": 2002,\n      \"claim\": \"Double knockout of Dlx5 and Dlx6 revealed their combined essential roles in jaw identity (homeotic mandible-to-maxilla transformation) and limb outgrowth (SHFM phenotype), establishing them as homeotic-like regulators in Hox-free territories.\",\n      \"evidence\": \"Dlx5/Dlx6 double knockout mice with morphological, histological, and skeletal analysis; transgenic Dlx5 rescue of limb phenotype\",\n      \"pmids\": [\"12000792\", \"12434331\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"The relative individual contributions of Dlx5 versus Dlx6 to each phenotype\",\n        \"Downstream target genes mediating the jaw homeotic transformation\"\n      ]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Extending the phenotypic spectrum, Dlx5/Dlx6 loss was shown to abolish dorsal otic structures and to positively regulate chondrogenesis with functional redundancy, broadening their roles to inner ear patterning and endochondral skeleton formation.\",\n      \"evidence\": \"Double KO mouse vestibular phenotype with in situ hybridization; limb bud mesenchymal differentiation assay with domain mutagenesis\",\n      \"pmids\": [\"16900517\", \"17027239\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether DLX5 and DLX6 have distinct domain-specific functions despite overlapping activity\",\n        \"Direct transcriptional targets in otic epithelium\"\n      ]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Chondrocyte-specific transgenic rescue demonstrated that DLX5/DLX6 drive chondrocyte hypertrophy cell-autonomously, not through indirect paracrine signals.\",\n      \"evidence\": \"Col2a1-Dlx5 transgenic mice rescuing Dlx5/6-null chondrocyte defects; histological analysis\",\n      \"pmids\": [\"19956613\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Direct DLX5/6 target genes in hypertrophic chondrocytes\",\n        \"Whether DLX6 alone is sufficient for the cell-autonomous rescue\"\n      ]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Loss of Dlx5/Dlx6 in GABAergic progenitors was shown to impair tangential migration and maturation of parvalbumin-positive cortical interneurons, with haploinsufficiency causing seizures, connecting DLX5/6 to cortical circuit function.\",\n      \"evidence\": \"Conditional/constitutive knockout, interneuron transplantation, immunohistochemistry, electrophysiology in mouse\",\n      \"pmids\": [\"20392955\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether DLX6 alone versus DLX5 alone contributes to interneuron migration\",\n        \"Mechanism by which DLX5/6 regulate CXCR4 expression\"\n      ]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"A SNP in the ultraconserved I56i intergenic enhancer was shown to reduce Dlx protein binding and enhancer activity in ganglionic eminences, and affinity purification identified GTF2I as a novel Dlx regulatory partner, linking enhancer variation to potential neurodevelopmental phenotypes.\",\n      \"evidence\": \"Transgenic reporter, in vitro binding, affinity purification in mouse\",\n      \"pmids\": [\"20702565\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"In vivo significance of the SNP in human neurodevelopmental disease\",\n        \"Whether GTF2I directly interacts with DLX proteins or acts through the enhancer alone\"\n      ]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Multiple studies in 2011 expanded DLX5/6 functions to a Hand2–Dlx5/6 negative feedback loop in mandible morphogenesis, ectethmoid nasal capsule formation from the anterior neural fold, striatal/amygdalar gene regulation by Dlx6 alone, and ovarian follicle maintenance via reciprocal Dlx5/Foxl2 regulation.\",\n      \"evidence\": \"Conditional KO and triple-mutant epistasis in mouse mandible; siRNA and grafting in chick neurula; Dlx6-LacZ knockin with expression array; heterozygous mouse ovarian phenotyping\",\n      \"pmids\": [\"21558373\", \"21270050\", \"21452241\", \"21505076\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether DLX6 has unique non-redundant functions in the striatum independent of DLX5\",\n        \"Direct transcriptional targets of DLX5/6 in granulosa cells\",\n        \"Whether the Hand2–Dlx feedback loop operates in human craniofacial development\"\n      ]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"A Dlx–Msx–BMP regulatory loop was delineated in the limb, with DLX5/6 epistatic over Msx2 in AER cells and operating via BMP in limb mesoderm, and Dlx5/6 were shown to be dispensable for Edn1/Ednra-mediated pharyngeal arch artery patterning.\",\n      \"evidence\": \"Triple mutant (Msx1;Dlx5;Dlx6) mice with ChIP; Dlx5/6 and Ednra KO with neural crest lineage tracing\",\n      \"pmids\": [\"23382810\", \"23933587\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Complete catalog of DLX5/6-bound cis-regulatory elements in the AER\",\n        \"Whether additional BMP-independent pathways link DLX5/6 to limb patterning\"\n      ]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"A LINE-1 insertion truncating the DLX6 homeodomain was identified as the causative mutation for Pierre Robin–like craniofacial defects in dogs, providing the first direct genetic link between DLX6 coding mutation and a Mendelian-like craniofacial phenotype.\",\n      \"evidence\": \"GWAS, sequencing, micro-CT in Nova Scotia Duck Tolling Retrievers\",\n      \"pmids\": [\"24699068\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Functional validation by allelic rescue or in vitro assay of the truncated protein\",\n        \"Whether analogous DLX6 mutations exist in human Pierre Robin sequence patients\"\n      ]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"DLX5/6 were positioned upstream of Wnt5a in AER organization and shown to be required for uterine adenogenesis, broadening their developmental regulatory network to Wnt signaling and reproductive tract morphogenesis.\",\n      \"evidence\": \"Double KO limb analysis with ex vivo Wnt5a rescue; conditional uterine KO (Pgr-Cre) with histology and expression analysis\",\n      \"pmids\": [\"26685160\", \"26512061\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\n        \"Whether DLX5/6 directly activate Wnt5a transcription or act through intermediaries\",\n        \"Target genes downstream of DLX5/6 in uterine gland progenitors\"\n      ]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"DLX5/6 were shown to antagonize cell proliferation at the G1/S checkpoint across multiple cell types, and their conditional loss in GABAergic neurons yielded reduced anxiety, lower adiposity, and extended lifespan, revealing systemic metabolic consequences of interneuron-specific DLX5/6 function.\",\n      \"evidence\": \"Overexpression with BrdU/flow cytometry in multiple cell lines; Vgat-Cre conditional KO with behavioral and metabolic phenotyping\",\n      \"pmids\": [\"31041891\", \"31514171\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether the cell cycle effect is direct transcriptional regulation or indirect\",\n        \"The neural circuit mechanism linking GABAergic DLX5/6 loss to metabolic and aging phenotypes\",\n        \"Whether posterior axis defects in Dlx5/6 null mice involve the same cell cycle mechanism\"\n      ]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"DLX6 was identified as a transcriptional activator of ATG7 in glioma via ChIP-validated promoter binding, placing DLX6 in a DANCR/miR-33b/DLX6/ATG7 axis promoting autophagy, extending DLX6's transcriptional targets beyond developmental contexts.\",\n      \"evidence\": \"ChIP assay, dual-luciferase reporter, siRNA knockdown, xenograft model in glioma cells\",\n      \"pmids\": [\"36601767\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\n        \"Whether DLX6-dependent ATG7 activation occurs in normal developmental tissues\",\n        \"Genome-wide binding profile of DLX6 in cancer cells\"\n      ]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key unresolved questions include the genome-wide direct transcriptional targets of DLX6 in developmental and disease contexts, the non-redundant functions of DLX6 versus DLX5, the structural basis for DLX6 homeodomain target specificity, and whether human DLX6 mutations cause Mendelian craniofacial or neurodevelopmental disorders.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\n        \"No genome-wide ChIP-seq for DLX6 in primary developmental tissues\",\n        \"No crystal or cryo-EM structure of DLX6 homeodomain–DNA complex\",\n        \"No confirmed pathogenic DLX6 coding variants in human genetic disease\"\n      ]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [2, 3, 9, 22]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [2, 3, 6, 10, 12, 22]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [2, 3, 9, 22]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [2, 3, 10, 12, 22]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 1, 5, 7, 8, 12, 15, 18]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [3, 13, 15]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\n      \"DLX5\",\n      \"DLX1\",\n      \"DLX2\",\n      \"HAND2\",\n      \"GTF2I\",\n      \"MSX2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}